Is choledocholithiasis a late complication of nonresectional therapies for hepatocellular carcinoma?

Hepato-Gastroenterology

Volumn 46, Issue 30, 1999, Pages 3091-3094

  Koda, Masahiko ^a   Murawaki, Yoshikazu ^a   Idobe, Yoko ^a   Horie, Yutaka ^a   Suou, Takeaki ^a   Kawasaki, Hironaka ^a   Ikawa, Shiro ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Choledocholithiasis; Hepatocellular carcinoma

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CLINICAL FEATURE; COMMON BILE DUCT STONE; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHOLANGIOGRAPHY; ENDOSCOPY, DIGESTIVE SYSTEM; ETHANOL; FEMALE; GALLSTONES; HUMANS; INJECTIONS, INTRA-ARTERIAL; LITHOTRIPSY; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032795704     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 1 Kanematsu T, Furuta T, Takenaka K, et al: A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10:98-102.
2. 2 Livraghi T, Giorgio A, Marin G, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
3. 3 Koda M, Okamoto K, Miyoshi Y, et al: Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma. Hepato-Gastroenterol 1994; 17:70-75.
4. 4 Liu C-L, Fan S-T: Nonresectional therapy for hepatocellular carcinoma. Am J Surg 1997; 173:358-365.
5. 5 Isobe H, Fukai T, Iwamoto H, et al: Liver abscess complication intratumoral ethanol injection therapy for HCC. Am J Gastroenterol 1990; 12:1646-1648.
6. 6 Koda M, Okamoto K, Miyoshi Y, et al: Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma. Gastrointest Radiol 1992; 17:167-169.
7. 7 de Sio I, Castellano L, Calandra M: Hemobilia following percutaneous ethanol injection for hepatocellular carcinoma in a cirrhosis patients. J Clin Ultrasound 1992; 20:621-623.
8. 8 Kurl S, Farin P, Rykonen H, et al: Intraperitoneal seeding from hepatocellular carcinoma following percutaneous ethanol injection therapy. Abdom Imaging 1997; 22:261-263.
9. 9 Shiina S, Niwa Y, Omata M: Percutaneous ethanol injection therapy for liver neoplasms. Semin Intervent Radiol 1993; 10:57-68.
10. 10 Ichida T, Van Thiel DH, Hassanein T: The medical management of hepatocellular carcinoma (HCC) in Japan: A review with implication for HCC seen in the west. Hepato-Gastroenterol 1996; 43:1575-1583.
11. 11 Liver Cancer Study Group of Japan: Survey and follow-up study of primary liver cancer in Japan: Report 12. Kyoto: Shinko-insatsu, 1996; p. 37.
12. 12 Del Olmo JA, Garcia F, Serra MA, et al: Prevalence and incidence of gallstone in liver cirrhosis. Scand J Gastroenterol 1997; 32:1061-1065.
13. 13 Dunnington G, Sampliner R, Kogan F, et al: Natural history of cholelithiasis in patients with alcoholic cirrhosis (Cholelithiasis in cirrhotic patients). Ann Surg 1987; 205:226-229.
14. 14 Hawes RH, Sherman S: Choledocholithiasis In: Haubrick WS, Schaffner F, Berk JE (Eds.). Bockus' Gastroenterology. 5th Edition. Philadelphia. WB Saunders Company, 1995; pp. 2745-2779.
15. 15 Sugiyama M, Atomi Y, Kuroda A, et al: Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopie spincterotomy? Ann Surg 1993; 218:68-73.
16. 16 Chijiwa K, Kozaki N, Naito T, et al: Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis. Am J Surg 1995; 170:356-360.